New drug Dostarlimab cures all patients in trial 'first time in history

A small clinical trial discovered that every single rectal cancer patient who got an experimental treatment saw their disease vanish, in what looks to be a miracle and a "first in history". According to the New York Times, 18 patients took a medicine named Dostarlimab for six months in a limited clinical trial done by Memorial Sloan Kettering Cancer Center, and all of them saw their tumours shrink at the end. Experts stated that the malignancy is undetectable by physical examination, endoscopy, positron emission tomography or PET scans, or MRI scans. This shows that Dostarlimab has the potential to be a 'possible' cancer cure for one of the most lethal tumours.

For Further Info:-https://bit.ly/3mpHiT4




Comments

Post a Comment

Popular posts from this blog

SCID Model Market is estimated to be US$ 61.95 million by 2030 with a CAGR of 4.6% during the forecast period

Image
  SCID Models Market   garnered a revenue of USD 43.50 Million in the year 2019 globally and has been foreseen to yield USD 61.95 Million by the year 2030 at a compound annual growth (CAGR) of 4.6% over the forecast period. Researchers are investigating the development of severe combined immunodeficient (SCID) pig models for translational cancer modelling. Several severe combined immunodeficient (SCID) pig models have been developed or genetically created in the previous decade. SCID pigs with NK cells but lacking in T and B cells, or defective in NK, T, and B cells for research investigations, have mutations in the ARTEMIS, IL2RG, or RAG1/2 genes, or combinations thereof. The report "Global SCID Model Market, By Model (Mouse, Pigs and Other), By Treatment (Stem Cell Therapy, Gene Therapy, and Enzyme Therapy), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030’’ Key Highlights:...
Read more

Non-alcoholic Steatohepatitis Biomarkers Market accounted for US$ 556.6 billion in 2019 and is estimated to be US$ 8177.9 billion by 2029 and is anticipated to register a CAGR of 31.3%

Image
Non-alcoholic steatohepatitis   is a progressive phase of non-alcoholic fatty liver disease (NAFLD), which is caused due to the excess fat accumulation leading to inflammation and damage resulting to liver scarring. NASH biomarkers are used as diagnostic tools to measure the severity of non-alcoholic steatohepatitis and for the liver damage assessment. Emerging advancements in technology in biomarker identification for NASH is supporting in the NASH biomarker development. The report " Global  Non-alcoholic Steatohepatitis Biomarkers Market, By  Type (Serum Biomarkers, Hepatic Fibrosis Biomarkers, Apoptosis Biomarkers, Oxidative Stress Biomarkers, and Others), By End-user (Pharma & CRO Industry, Hospitals, Diagnostic Labs, and Academic Research Institutes),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In January 2019, LabCorp. a leading global...
Read more

Healthcare Cyber Security Market is estimated to be US$ 51.7 billion by 2032 with a CAGR of 18.8% over the forecast period (2022-2032)

Image
  Healthcare Cyber Security is a strategic imperative for any organization in the medical industry, from healthcare providers to insurance companies to pharmaceutical, biotechnology, and medical device companies. It includes various measures to protect organizations from external and internal cyber-attacks and to ensure availability of medical services, proper operation of medical systems and equipment, preservation of confidentiality and integrity of patient data & compliance with industry regulations. Cyber security is a critical component of any healthcare organization's operations, healthcare data is considered one of the most valuable commodities sold on the information black market, and as a result, healthcare facilities are prime targets for cybercriminals. But in the healthcare sector, cyber security requires a more specialized, focused strategy to preserve the privacy, integrity and availability of highly sensitive medical information, the most valuable healthcare dig...
Read more